Results 31 to 40 of about 9,571 (146)

Pharmacoeconomics expediency of application of the combined preparation of Vezomni in comparison with a combination of Tamsulosin and Solifenacin in the form of monopreparations

open access: yesКачественная клиническая практика, 2018
Aim. Conduct a comparative assessment of the pharmacoeconomic e‘cacy of using the combination Vezomni as compared to a combination of tamsulosin and solifenacin in the form of monopreparations in men with symptoms of the lower urinary tract against a ...
S. K. Zyryanov, I. N. Dyakov
doaj   +1 more source

Budget impact of eribulin in metastatic breast cancer in Russian Federation

open access: yesКачественная клиническая практика, 2018
Breast cancer is one of the most wide spread oncological disease and metastatic breast cancer is very severe, because of its high resistance. One of the recent drugs aimed for this group of patients is еribulin, which is microtubules dynamics inhibitor ...
S. K. Zyryanov, D. Yu. Belousov
doaj  

Pharmacoeconomic analysis of botulinum toxins as treatment for treatment of adult upper limb spasticity

open access: yesКачественная клиническая практика, 2019
Actuality. A major problem for rehabilitating patients after a stroke, other major cerebrovascular events or trauma (such as traumatic brain injury (TBI)) is increased muscle tone (spasticity) which in turn causes impairments of mobility and formation of
Dmitry Belousov   +2 more
doaj   +1 more source

PHARMACOECONOMIC ANALYSIS OF NEW ORAL ANTICOAGULANTS IN VTE

open access: yes, 2017
Представлены результаты фармакоэкономического исследования новых пероральных антикоагулянтов в лечении венозных тромбоэмболических осложнений. Показано, что применение ривароксабана, дабигатрана и апиксабана снижает прямые расходы системы здравоохранения
O. Shatalova   +3 more
semanticscholar   +1 more source

Assessment of the economic feasibility of gadoversetamida (OptiMARK) MRI with intravenous contrast

open access: yesКачественная клиническая практика, 2018
Gadolinium based contrast agents are widely used in MRI in a diagnostic of variety of pathologies. The quality of contrast enhancement depends on the total dose. The aim of the study is to conduct a health economic evaluation of gadoversetamide (OptiMARK,
A. S. Kolbin, I. A. Vilum
doaj  

Pharmacoeconomic analysis of subdermal tocilizumab in patients with rheumatoid arthritis

open access: yesКачественная клиническая практика, 2018
Rheumatoid arthritis (RA) is an autoimmune disease with unknown etiology that is characterized by chronic, erosive arthritis (synovitis), usually affecting more than five joints, and systemic impairment of internal organs.
S. K. Zyryanov   +2 more
doaj  

Economic analysis of the effectiveness of complex rehabilitation in children with spastic forms of cerebral palsy with injections of botulinum neurotoxin type A and without it

open access: yesКачественная клиническая практика, 2018
Purpose. Comparative economic analysis of complex rehabilitation of children with cerebral palsy (CP) with and without injections of botulinum neurotoxin type A (Dysport®, BoNT-A). Materials and methods.
V. A. Zmanovskaya   +4 more
doaj   +1 more source

Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia

open access: yesКачественная клиническая практика, 2018
Relevance. ‹The most effective treatment for focal dystonia (blepharospasm (BsP) and cervical dystonia (CD)) is use of botulinum toxin, including onabotulinumtoxinА (BoNTA-Ona), incobotulinumtoxin А (BoNTA-Inco), abobotulinumtoxinА (BoNTA-Abo).
A. E. Cheberda   +2 more
doaj   +1 more source

Clinico-economic analysis of PD-1 inhibitors and combinations of BRAF and MEK inhibitors for the treatment of metastatic melanoma with a BRAF V600 gene mutation

open access: yesКачественная клиническая практика, 2018
The high prevalence of BRAF V600 gene mutation in the Russian Federation and the cost of treatment the metastatic melanoma (MM) with immuno-oncology and combined targeted drugs make it relevant to assess the clinical and economic feasibility of their use.
D. Yu. Belousov   +3 more
doaj   +1 more source

Health technology assessment of hyaluronans in osteoarthritis treatment

open access: yesКачественная клиническая практика, 2018
Health technology assessment has been performed for osteoarthritis treatment. Several technologies were evaluated — NSAIDs, steroid therapy and hyaluronans viscosupplementation for inter joint injection.
A. S. Kolbin   +3 more
doaj  

Home - About - Disclaimer - Privacy